ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,185Medicare Part D Prescriptions Filled, Including Refills

Rank: 234 out of 2429

$430K Total Retail Price of All Prescriptions

Rank: 382 out of 2429

294 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 294 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

14% of this provider’s 294 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 8,138 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 767 613 1 2
LEVOTHYROXINE SODIUM 404 343 2 3
HYDROCHLOROTHIAZIDE 393 336 3 10
SIMVASTATIN 349 298 4 1
AMLODIPINE BESYLATE 331 294 5 4
METFORMIN HCL 327 241 6 8
METOPROLOL TARTRATE 324 270 7 9
OMEPRAZOLE 288 224 8 7
WARFARIN SODIUM 262 242 9 11
FUROSEMIDE 256 236 10 5
HYDROCODONE-ACETAMINOPHEN 211 145 S3 11 6
ATORVASTATIN CALCIUM 199 165 12 13
TRAMADOL HCL 168 113 13 17
GABAPENTIN 166 139 14 18
POTASSIUM CHLORIDE 161 138 15 14
METOPROLOL SUCCINATE 159 125 16 12
GLIMEPIRIDE 157 133 17 51
ATENOLOL 147 130 18 15
GLYBURIDE 134 122 R 19 64
CRESTOR 112 84 20 25
SERTRALINE HCL 107 72 21 23
NAPROXEN 101 79 22 75
PRAVASTATIN SODIUM 98 81 23 16
FENOFIBRATE 97 54 24 48
TRICOR 94 44 25 125
RANITIDINE HCL 93 48 26 24
CLOPIDOGREL 91 74 27 31
NEXIUM 90 75 28 37
LOSARTAN POTASSIUM 85 76 29 22
KLOR-CON 10 83 71 30 89
JANUVIA 78 64 31 66
ALLOPURINOL 77 54 32 33
LOVASTATIN 75 59 33 30
DIGOXIN 72 64 34 43
DONEPEZIL HCL 70 69 35 26
TAMSULOSIN HCL 63 49 36 29
PLAVIX 62 46 37 44
TRAZODONE HCL 62 36 37 50
PROPRANOLOL HCL 61 61 39 119
LANTUS 59 57 40 45
CITALOPRAM HBR 53 43 41 19
NIASPAN 52 23 42 113
ENALAPRIL MALEATE 51 44 43 32
OXYBUTYNIN CHLORIDE ER 51 51 43 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.